TipRanks
Skye Bioscience (SKYE)
NASDAQ:SKYE
US Market
SKYE
Skye Bioscience
RESEARCH TOOLSreports
Want to see SKYE full AI Analyst Report?

Skye Bioscience (SKYE) Income Statement

1,007 Followers

Skye Bioscience Income Statement

Last quarter (Q2 2026), Skye Bioscience's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Skye Bioscience's net income was $-10.79M. See Skye Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -723.35K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 57.44M$ 30.19M$ 34.74M$ 18.31M$ 7.85M
Depreciation and Amortization
$ 723.35K$ 298.64K$ 124.25K$ 115.00K$ 34.13K
EBITDA
$ -55.20M$ -25.29M$ -36.62M$ -18.70M$ -7.72M
Operating Income
$ -58.16M$ -30.19M$ -34.74M$ -18.31M$ -7.85M
Other Income/Expenses
$ 2.24M$ 3.64M$ -2.91M$ -1.16M$ -672.37K
Pretax Income
$ -55.92M$ -26.56M$ -37.64M$ -19.47M$ -8.52M
Net Income
$ -55.92M$ -26.57M$ -37.64M$ -19.48M$ -8.52M
Per Share Metrics
Basic EPS
$ -11.28$ -5.84$ -42.96$ -70.16$ -40.00
Diluted EPS
$ -11.28$ -5.84$ -42.96$ -70.16$ -40.00
Weighted Average Shares Outstanding
 4.96M 4.56M 875.75K 277.63K 203.30K
Weighted Average Shares Outstanding (Diluted)
 4.96M 4.56M 875.75K 277.63K 203.30K
Currency in USD

Skye Bioscience Earnings and Revenue History